Form 4 for ISRG Intuitive Surgical
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001035267-25-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-28 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | +1,002 | 6,367 | +19% | $0 |
| D | 2025-03-03 | 2025-02-27 | ISRG | Curet Myriam | EVP, Chief Medical Off | A - Grant | $0.00 | +5,012 | 7,766 | +182% | $0 |
| D | 2025-03-03 | 2025-03-03 | ISRG | Curet Myriam | EVP, Chief Medical Off | S - Sale+OE | $577.30 | -3,031 | 353 | -90% | -$1.75M |
| DM | 2025-03-03 | 2025-02-28 | ISRG | Curet Myriam | EVP, Chief Medical Off | F - Tax | $563.77 | -2,983 | 3,384 | -47% | -$1.68M |
| D | 2025-03-03 | 2025-02-28 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | -1,002 | 1,002 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | M | A | 1,002 | $0.00 | 6,367 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-27 | A | A | 5,012 | $0.00 | 7,766 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-03 | S | D | 3,031 | $577.30 | 353 | D | — | — | (F5) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $573.78 to $582.10 as follows: 562 shares sold at $573.78 ; 300 shares sold at $575 to $575.78; 619 shares sold at $576.35 to $577.20; 1,145 shares sold at $578 to $578.88; 105 shares sold at $579.48 to $579.89;and 300 shares sold at $582.03 to $582.10. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2025-02-28 | F | D | 497 | $563.77 | 5,870 | D | — | — | |
| 5 | Common | Common Stock | 2025-02-28 | F | D | 2,486 | $563.77 | 3,384 | D | — | — | |
| 6 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 1,002 | $0.00 | 1,002 | D | $0.00 · — to 2026-02-28 | 1,002 Common Stock | (F6) Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. |